Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.

Peterson BA, Petroni GR, Frizzera G, Barcos M, Bloomfield CD, Nissen NI, Hurd DD, Henderson ES, Sartiano GP, Johnson JL, Holland JF, Gottlieb AJ.

J Clin Oncol. 2003 Jan 1;21(1):5-15.

PMID:
12506163
2.

Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma.

Ozer H, Anderson JR, Peterson BA, Budman DR, Cooper MR, Kennedy BJ, Silver RT, Henderson ES, Duggan DB, Barcos M, et al.

Med Pediatr Oncol. 1994;22(4):228-35.

PMID:
8107652
3.

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.

Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA.

N Engl J Med. 1992 Nov 19;327(21):1478-84.

4.

Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.

Kornblith AB, Anderson J, Cella DF, Tross S, Zuckerman E, Cherin E, Henderson ES, Canellos GP, Kosty MP, Cooper MR, et al.

Cancer. 1992 Nov 15;70(10):2508-16.

PMID:
1384949
6.

The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.

Ellison RR, Mick R, Cuttner J, Schiffer CA, Silver RT, Henderson ES, Woliver T, Royston I, Davey FR, Glicksman AS, et al.

J Clin Oncol. 1991 Nov;9(11):2002-15.

PMID:
1941059
7.

Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study.

Cuttner J, Mick R, Budman DR, Mayer RJ, Lee EJ, Henderson ES, Weiss RB, Paciucci PA, Sobol R, Davey F, et al.

Leukemia. 1991 May;5(5):425-31.

PMID:
2033963
8.

Splenectomy in advanced chronic lymphocytic leukemia.

Thiruvengadam R, Piedmonte M, Barcos M, Han T, Henderson ES.

Leukemia. 1990 Nov;4(11):758-60.

PMID:
2232888
9.

A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.

Gottlieb AJ, Anderson JR, Ginsberg SJ, Bloomfield CD, Norton L, Barcos M, Peterson BA, Nissen N, Henderson ES, Holland JF.

Cancer. 1990 Nov 1;66(9):1888-96.

PMID:
1699653
10.

A case of aggressive multiple myeloma with convoluted and multilobated plasma cell nuclei and no visible nucleoli.

Islam A, Noyes S, Henderson ES.

Br J Haematol. 1990 Oct;76(2):306-7. No abstract available.

PMID:
2133377
12.

Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials.

Kornblith AB, Anderson J, Cella DF, Tross S, Zuckerman E, Cherin E, Henderson ES, Weiss RB, Cooper MR, Silver RT, et al.

Oncology (Williston Park). 1990 May;4(5):93-101; discussion 104.

PMID:
1696491
13.
14.

Wide-field radiation therapy plus simultaneous chemotherapy for refractory Hodgkin's disease.

Gomez GA, Krishnamsetty RM, Han T, Henderson ES.

Med Pediatr Oncol. 1989;17(1):9-14.

PMID:
2913482
15.

Electron microscopic evidence for hemopoietic and stromal cells in murine long-term bone marrow cultures.

Islam A, Bielat KL, Glomski C, Henderson ES.

J Med. 1989;20(3-4):217-28.

PMID:
2809420
17.
18.

In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates.

Biddle WC, Haruta Y, Seon BK, Henderson ES, Sarcione EJ.

Leuk Res. 1989;13(8):699-707.

PMID:
2529399
19.

Primary prostatic involvement in non-Hodgkin lymphoma.

Patel DR, Gomez GA, Henderson ES, Gamarra M.

Urology. 1988 Aug;32(2):96-8.

PMID:
3400147
20.
21.

Value of long-core biopsy in the detection of discrete bone marrow lesions.

Islam A, Henderson ES.

Histopathology. 1988 Jun;12(6):641-8.

PMID:
3166450
22.

Cytogenetic studies in chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia: a progress report.

Han T, Sadamori N, Block AM, Xiao H, Henderson ES, Emrich L, Sandberg AA.

Nouv Rev Fr Hematol. 1988;30(5-6):393-5.

PMID:
3222149
24.

Prognostic significance of karyotypic abnormalities in B cell chronic lymphocytic leukemia: an update.

Han T, Henderson ES, Emrich LJ, Sandberg AA.

Semin Hematol. 1987 Oct;24(4):257-63. Review.

PMID:
3317853
27.

Treatment strategies for "high-risk" leukemia.

Henderson ES.

J Clin Oncol. 1987 May;5(5):689-91. No abstract available.

PMID:
3572461
28.

Salvage chemotherapy for advanced Hodgkin's disease.

Garbes ID, Gomez GA, Han T, Henderson ES.

Med Pediatr Oncol. 1987;15(1):45-8.

PMID:
3494184
29.

Cytogenetic studies in hairy cell leukemia.

Ohyashiki K, Ohyashiki JH, Takeuchi J, Han T, Henderson ES, Sandberg AA.

Cancer Genet Cytogenet. 1987 Jan;24(1):109-17.

PMID:
3491670
30.

Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma.

Ozer H, Anderson JR, Peterson BA, Budman DR, Henderson ES, Bloomfield CD, Gottlieb A.

Invest New Drugs. 1987;5 Suppl:S27-33.

PMID:
3298131
31.

Current therapy of acute and chronic leukemia in adults.

Henderson ES, Han T.

CA Cancer J Clin. 1986 Nov-Dec;36(6):322-50. Review. No abstract available.

32.

Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study.

Davis RB, Van Echo DA, Leone LA, Henderson ES.

Cancer Treat Rep. 1986 Sep;70(9):1125-6. No abstract available.

PMID:
3742493
33.

Primary chemotherapy for localized non-Hodgkin's lymphomas with diffuse histologic characteristics. Preliminary report of a prospective study.

Gomez GA, Reddy S, Krishnamsetty RM, Barcos M, Nava H, Han T, Ozer H, Henderson ES.

Arch Intern Med. 1986 Sep;146(9):1785-8.

PMID:
3489446
34.

Treatment of early--stages I and II--nodular, poorly differentiated lymphocytic lymphoma.

Gomez GA, Barcos M, Krishnamsetty RM, Panahon AM, Han T, Henderson ES.

Am J Clin Oncol. 1986 Feb;9(1):40-4.

PMID:
3513536
35.

Procarbazine-induced interstitial pneumonitis with a normal chest x-ray: a case report.

Garbes ID, Henderson ES, Gomez GA, Bakshi SP, Parthasarathy KL, Castillo NB.

Med Pediatr Oncol. 1986;14(4):238-41.

PMID:
3747943
36.

Clinical significance of serum lactate dehydrogenase in chronic lymphocytic leukemia.

Han T, Emrich LJ, Ozer H, Reese PA, Gajera R, Gomez GA, Henderson ES, Bloom ML, Bhargava A, Fitzpatrick J.

N Y State J Med. 1985 Dec;85(12):685-90. No abstract available.

PMID:
3911124
37.

Clonal chromosome abnormalities in prison-acquired lymphoproliferative syndrome.

Takeuchi J, Ochi H, Han T, Ozer H, Henderson ES, Sandberg AA.

Cancer Genet Cytogenet. 1985 Feb 1;15(1-2):7-16.

PMID:
3967219
38.

Cytogenetic studies of a diffuse mixed cell lymphoma of T cell origin.

Takeuchi J, Ochi H, Minowada J, Barcos M, Ozer H, Henderson ES, Sandberg AA.

Cancer Genet Cytogenet. 1985 Jan 15;14(3-4):257-66.

PMID:
3871349
39.

Salvage treatment for patient with multiple myeloma refractory to alkylating agents.

Gomez GA, Han T, Ozer H, Henderson ES.

Med Pediatr Oncol. 1985;13(6):325-9.

PMID:
4046971
40.

Simultaneous low-dose radiation and low-dose chemotherapy in the treatment of advanced Hodgkin's disease.

Gomez GA, Panahon AM, Stutzman L, Han T, Ozer H, Henderson ES.

Am J Clin Oncol. 1984 Oct;7(5):457-64.

PMID:
6391142
41.

Cytogenetic studies in 77 patients with chronic lymphocytic leukemia: correlations with clinical, immunologic, and phenotypic data.

Han T, Sadamori N, Ozer H, Gajera R, Gomez GA, Henderson ES, Bhargava A, Fitzpatrick J, Minowada J, Bloom ML, et al.

J Clin Oncol. 1984 Oct;2(10):1121-32.

PMID:
6333488
42.

Staging laparotomy and splenectomy in early Hodgkin's disease. No therapeutic benefit.

Gomez GA, Reese PA, Nava H, Panahon AM, Barcos M, Stutzman L, Han T, Henderson ES.

Am J Med. 1984 Aug;77(2):205-10.

PMID:
6380286
43.

Benign monoclonal B cell lymphocytosis--a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients.

Han T, Ozer H, Gavigan M, Gajera R, Minowada J, Bloom ML, Sadamori N, Sandberg AA, Gomez GA, Henderson ES.

Blood. 1984 Jul;64(1):244-52.

PMID:
6610446
44.

Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B.

Gottlieb AJ, Weinberg V, Ellison RR, Henderson ES, Terebelo H, Rafla S, Cuttner J, Silver RT, Carey RW, Levy RN, et al.

Blood. 1984 Jul;64(1):267-74.

PMID:
6375760
45.

Distinctive sensitivity of some T-leukemia cell lines to L-asparaginase.

Koishi T, Minowada J, Henderson ES, Ohnuma T.

Gan. 1984 Mar;75(3):275-83.

PMID:
6609860
46.

Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia.

Han T, Ozer H, Sadamori N, Emrich L, Gomez GA, Henderson ES, Bloom ML, Sandberg AA.

N Engl J Med. 1984 Feb 2;310(5):288-92.

PMID:
6690952
47.

Large mediastinal mass in Hodgkin's disease. Results of two treatment modalities.

Gomez GA, Panahon AM, Stutzman L, Moayeri H, Park JJ, Barcos M, Kim U, Han T, Henderson ES.

Am J Clin Oncol. 1984 Feb;7(1):65-73.

PMID:
6695853
48.
49.

Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin's disease.

Gomez GA, Park JJ, Panahon AM, Parthasarathy KL, Pearce J, Reese P, Bakshi S, Henderson ES.

Cancer Treat Rep. 1983 Dec;67(12):1099-103.

PMID:
6652627
50.

Possible specific chromosome change in prolymphocytic leukemia.

Sadamori N, Han T, Minowada J, Bloom ML, Henderson ES, Sandberg AA.

Blood. 1983 Oct;62(4):729-36.

PMID:
6882921

Supplemental Content

Loading ...
Support Center